ALICIA VATTER: Open Payments
NPI 1265107023 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,070 in 153 payments from 19 companies in 2025. Trend: 2023 $3,790 · 2024 $5,367 · 2025 $3,070
Food & beverage: $2,900Education: $170
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 43 | $784 |
| ABBVIE INC. | 32 | $569 |
| LEO Pharma Inc. | 13 | $329 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $206 |
| Regeneron Healthcare Solutions, Inc. | 8 | $200 |
| Novartis Pharmaceuticals Corporation | 10 | $199 |
| Incyte Corporation | 4 | $106 |
| Organon LLC | 7 | $95 |
| Amgen Inc. | 4 | $87 |
| Galderma Laboratories, L.P. | 3 | $79 |
Products named: TREMFYA, SKYRIZI, ADBRY, DUPIXENT, RINVOQ, ILUMYA, COSENTYX, OPZELURA.
Industry payments across RI — which companies pay providers there.
